Scientists have found that glucose plays a significant role in how the brain functions.

Published Date: 26 Apr 2023

Nearly a quarter of the body's sugar energy, or glucose, is consumed daily by the human brain, which also has a sweet tooth. Now, scientists from the Gladstone Institutes and UC San Francisco (UCSF) have provided fresh insight into how.

Read Full News

Latest News

South Africa's IDexis Appeals Court Ruling Over Compounded Weight-loss Drugs

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ⁠of compounded weight-loss medicines, disputing...

Study Flags Need to Monitor Frailty Risks With GLP-1 Drugs for Older Adults

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study...

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Do Infant Food Portion Sizes Matter for Later Overweight?

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Screening for Diabetes at Urgent Care Could Save Lives

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.

Semaglutide Linked to Rare Brain Illness

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ⁠of compounded weight-loss medicines, disputing...

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study...

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

News All Time

1 in 9 Americans Now on GLP-1s

A recent Gallup poll shows that the use of GLP-1 drugs in the US has surged to a record high, with 11% of US adults currently using these medications and 15% reporting having used them at some point.

Manometry May Detect Hidden Reflux in Obesity

High-resolution impedance manometry identifies physiologic evidence of reflux in many patients with obesity whose gastroesophageal reflux disease may be missed on the basis of symptoms alone.

Exercise and Male Fertility: When Is More Too Much?

Moderate exercise supports semen quality and hormonal health, but prolonged high-intensity training may impair fertility, particularly when energy intake is inadequate.

Sleeve Gastrectomy and Hernia Repair Hold Up Long Term

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

New AI Imaging Detects ‘Striking’ Obesity-Related Neuropathy

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

Constipation Common but Rarely New in GLP-1 Users

Constipation is already prevalent in patients with obesity initiating GLP-1 therapy, but only a small proportion develop new symptoms after beginning treatment.

Menopausal Hormone Therapy Tied to Risk for Eye Misalignment

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

Liver Steatosis Common in Women Referred for PMOS

A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.

CGM in Primary Care Improves Diabetes Outcomes

Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.

Safe Antibiotics in Pregnancy and Breastfeeding

A new ENTIS webinar highlights evidence-based antibiotic choices in pregnancy and lactation, including when amoxicillin, fosfomycin, and macrolides can be used safely.

Novo Nordisk Launches Weekly Insulin Shot Awiqli in India

Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete with daily-dose options on the market.

Delayed TED Underrecognized Following MS Treatment

Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory therapy including alemtuzumab.

China Adds Second GLP-1 Diabetes Drug to Essential Medicine List

China will add a second GLP-1 drug, used to treat diabetes, to a list of essential ⁠drugs all public hospitals are required to prioritise having in their formulary, a...

What’s New in Vulvar Lichen Sclerosus Treatment?

For patients with vulvar lichen sclerosus who do not respond to standard care, lasers, JAK inhibitors, and PRP are drawing growing clinical interest.

When Fragmented Care Becomes the Whole Patient’s Kryptonite

The hyperspecialization of modern medicine partitions patients into isolated organs, driving up systemic costs, and leaving many in a state of clinical abandonment.

Early Weight Swings Tied to Reduced Diet Success

Higher short-term weight variability during the first 12 weeks is linked to less subsequent long-term weight loss in healthy adults without obesity on a calorie-restriction diet.

Recommended News For You

Telemedicine services linked to reducing excess mortality

The need for more Latinx participants in Alzheimer's trials is urgent.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

Review looks at potential treatment targets in the tumor microenvironment.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

Recommended Articles For You

Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology 

Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options 

Emerging Models in Oncology for Specialists 

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

2.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

3.

Chemo causes lasting physical decline in breast cancer survivors

4.

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

5.

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

1.

Integrated Trends in Hematology for Modern Medicine

2.

The Benefits and Risks of Transurethral Resection of Bladder Tumor 

3.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

4.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

5.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot